
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Income Statement | ||||||
Revenue | $2.8B | $2.8B | $2.9B | $681.4M | $731.1M | |
Gross Profit | $2.2B | $2.2B | $2.4B | $540.2M | $590.2M | |
Operating Income | $421M | $645M | $729.5M | $140.1M | $158.9M | |
EBITDA | $531.6M | $760.2M | $824.4M | $168.1M | $181.4M | |
Diluted EPS | $5.40 | $8.35 | $10.54 | $2.00 | $2.48 |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $1.3B | $1.7B | $1.8B | $2B | $2.3B | |
Total Assets | $4.5B | $5.1B | $5.2B | $5.4B | $5.9B | |
Current Liabilities | $1.3B | $1.8B | $1.5B | $1.5B | $1.5B | |
Total Liabilities | $2.5B | $2.7B | $2.5B | $2.5B | $2.6B | |
Total Equity | $2B | $2.4B | $2.7B | $2.9B | $3.3B | |
Total Debt | $378.7M | $359.4M | -- | -- | -- |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | $524.3M | $741.8M | $864.8M | $221.6M | $256.6M | |
Cash From Investing | $232.6M | -$63M | -$42.8M | -$39.9M | -$20.6M | |
Cash From Financing | -$605.7M | -$512.1M | -$465.1M | -$101.2M | -$129.6M | |
Free Cash Flow | $482.7M | $692.9M | $834.4M | $212.2M | $246.1M |
F5 is a market leader in the application delivery controller market. The company sells products for security, application performance, and automation. Its three customer verticals are enterprises, service providers, and government entities. Revenue is evenly split between its services business and products business with revenue trending toward products due to software adoption. The Seattle-based firm was incorporated in 1996, and went public in 1999.
In the current month, FFIV has received 1 Buy ratings 11 Hold ratings, and 0 Sell ratings. The FFIV average analyst price target in the past 3 months is $296.93.
According to analysts, the consensus estimate is that F5 share price will rise to $296.93 per share over the next 12 months.
Analysts are divided on their view about F5 share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that F5 is a Sell and believe this share price will drop from its current level to $260.00.
The price target for F5 over the next 1-year time period is forecast to be $296.93 according to 12 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 11 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for F5 is a Hold. 11 of 12 analysts rate the stock a Hold at this time.
You can purchase shares of F5 via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase F5 shares.
F5 was last trading at $300.33 per share. This represents the most recent stock quote for F5. Yesterday, F5 closed at $293.12 per share.
In order to purchase F5 stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.